Satoshi Yamana
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Successful treatment of tofacitinib-refractory scleritis associated with multiple systemic inflammatory diseases using upadacitinib.
Journal: Immunological medicine
Published: November 20, 2025
A NOVEL SHORT INTRAOCULAR ENDOSCOPE WITH EXTENDED DEPTH OF FOCUS: Evaluation of the Observation Field During Vitrectomy.
Journal: Retina (Philadelphia, Pa.)
Published: October 21, 2025
Molecular Variations in Glycoprotein B of Asian Human Cytomegalovirus: Potential Impact on Virus Entry and Immune Evasion in Ocular Diseases.
Journal: Journal of medical virology
Published: August 06, 2025
Initial clinical use of the intraocular endoscope holding robot in pars plana vitrectomy.
Journal: Japanese journal of ophthalmology
Published: June 11, 2025
Evaluation on the clinical findings and allergological factors of local allergic conjunctivitis and non-local allergic conjunctivitis.
Journal: Scientific reports
Published: October 21, 2024
Genetic Risk Stratification of Primary Open-Angle Glaucoma in Japanese Individuals.
Journal: Ophthalmology
Published: December 24, 2023
Functions of mucosal associated invariant T cells in eye diseases.
Journal: Frontiers in immunology
Published: November 20, 2023
Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan.
Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan.
Journal: Ocular immunology and inflammation
Published: November 02, 2023
Corrigendum: Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Journal: Frontiers in immunology
Published: December 15, 2022
Intraocular human cytomegaloviruses of ocular diseases are distinct from those of viremia and are capable of escaping from innate and adaptive immunity by exploiting HLA-E-mediated peripheral and central tolerance.
Journal: Frontiers in immunology
Published: July 31, 2022
Long-term outcomes of infliximab in patients with Behçet's disease-associated uveitis.
Journal: International ophthalmology
Published: December 19, 2021
Last Updated: 09/26/2026